Inflammatory breast cancer (IBC): clues for targeted therapies-Reference-Cited by-同舟云学术

Inflammatory breast cancer (IBC): clues for targeted therapies

Published:2013-06-21 Issue:1 Volume:140 Page:23-33
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Fernandez Sandra V.,Robertson Fredika M.,Pei Jianming,Aburto-Chumpitaz Lucy,Mu Zhaomei,Chu Khoi,Alpaugh R. K.,Huang Yong,Cao Yu,Ye Zaiming,Cai Kathy Q.,Boley Kimberly M.,Klein-Szanto Andres J.,Devarajan Karthik,Addya Sankar,Cristofanilli Massimo

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-013-2600-4.pdf

Reference40 articles.

1. Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH (2005) Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst 97:966–975

2. Chia S, Swain SM, Byrd DR, Mankoff DA (2008) Locally advanced and inflammatory breast cancer. J Clin Oncol 26:786–790

3. Dawood S et al (2011) Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study. Cancer 117:1819–1826

4. Robertson FM et al (2010) Inflammatory breast cancer: the disease, the biology, the treatment. CA Cancer J Clin 60:351–375

5. Cristofanilli M et al (2007) Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease. Cancer 110:1436–1444

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted dual degradation of HER2 and EGFR obliterates oncogenic signaling, overcomes therapy resistance, and inhibits metastatic lesions in HER2-positive breast cancer models;Drug Resistance Updates;2024-05

2. TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer;Breast Cancer Research;2024-01-31

3. Comprehensive Characterization of Immune Cell Infiltration Characteristics and Drug Sensitivity Analysis in Inflammatory Breast Cancer Based on Bioinformatic Strategy;Biochemical Genetics;2023-07-30

4. Diffuse breast cancer (epidemiology, clinic);Health care of Tajikistan;2023-03-30

5. Sensitization of Resistant Cells with a BET Bromodomain Inhibitor in a Cell Culture Model of Deep Intrinsic Resistance in Breast Cancer;Cancers;2023-03-29